| Literature DB >> 25582708 |
David Pérez-Pascual1, Esther Gómez, José A Guijarro.
Abstract
Flavobacterium psychrophilum is an important fish pathogen, responsible for Cold Water Disease, with a significant economic impact on salmonid farms worldwide. In spite of this, little is known about the bacterial physiology and pathogenesis mechanisms, maybe because it is difficult to manipulate, being considered a fastidious microorganism. Mutants obtained using a Tn4351 transposon were screened in order to identify those with alteration in colony morphology, colony spreading and extracellular proteolytic activity, amongst other phenotypes. A F. psychrophilum mutant lacking gliding motility showed interruption of the FP1638 locus that encodes a putative type-2 glycosyltransferase (from here on referred to as fpgA gene, Flavobacterium psychrophilum glycosyltransferase). Additionally, the mutant also showed a decrease in the extracellular proteolytic activity as a consequence of down regulation in the fpgA mutant background of the fpp2-fpp1 operon promoter, responsible for the major extracellular proteolytic activity of the bacterium. The protein glycosylation profile of the parental strain showed the presence of a 22 kDa glycosylated protein which is lost in the mutant. Complementation with the fpgA gene led to the recovery of the wild-type phenotype. LD50 experiments in the rainbow trout infection model show that the mutant was highly attenuated. The pleiotropic phenotype of the mutant demonstrated the importance of this glycosyltranferase in the physiology and virulence of the bacterium. Moreover, the fpgA mutant strain could be considered a good candidate for the design of an attenuated vaccine.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25582708 PMCID: PMC4293000 DOI: 10.1186/s13567-014-0124-5
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Bacterial strains, plasmids and primers used in this study
|
|
|
|
|---|---|---|
| Plasmidsa | ||
| pEP4351 |
| [ |
| pCP23 | ColE1 ori, (pCP1 ori), Apr (Tcr), | [ |
| pCP23-fpgA |
| This study |
| pCP23-Gfpp2 | pCP23-G carrying | [ |
| Bacterial strains | ||
|
| ||
| THC02/90 | Wild-type. | [ |
| fpgA− |
| This study |
| fpgA+ | Mutant ΔFP1638 carrying pCP23-FP1638 plasmid, complemented strain. | This study |
| THC02/90-G | THC02/90 strain carrying pCP23-G plasmid | [ |
| THC02/90 -fpp2 | THC02/90 strain carrying pCP23-Gfpp2 plasmid | [ |
| fpgA− -fpp2 | ΔFP1638 strain carrying pCP23-Gfpp2 plasmid | [ |
|
| ||
| S17-1 | λ | [ |
| BW19851 | RP4-2 | [ |
| Primersb | ||
| 26-F | 5′ACTG | This study |
| 26-R | 5′ ACTG | This study |
| TN-1 | 5′ GGACCTACCTCATAGACAA 3′ | [ |
| IS4351-F | 5′ TCAGAGTGAGAGAAAGGG 3′ | [ |
| promfpp2-F | 5′ ATCA | [ |
| promfpp2-R | 5′ GATT | [ |
aAntibiotic resistance phenotypes: ampicillin, Apr; tetracycline, Tcr; erythromycin, Emrb. Antibiotic resistance phenotypes and other features listed in parentheses are those expressed by F. psychrophilum but not by E. coli.
bRestriction sites for cloning are in bold.
Figure 1Genomic organization of the region surrounding the FP1638 ( ) gene in The direction of transcription is indicated by arrows. The position of a putative promoter (P) involved in the regulation of both the FP1637 and FP1638 gene (separated by 4 bp) is indicated. Transposon insertion is located at position 774 of the fpgA locus.
Figure 2Growth, extracellular proteolytic activity and colony spreading of wild-type and fpgA strains. (A) Growth curve at 12 °C in NBF medium, monitored by determining OD525. (■) wild-type and (●) fpgA− strains. Extracellular caseinolytic activity in cell-free supernatants was determined with azocasein as described by Secades et al. [38]. (□) wild-type and (○) fpgA− strains. EU, enzyme units. (B) Colony spreading of F. psychrophilum strains grown on 1/6NA for 96 h at 20 °C according to Pérez-Pascual et al. [37]. (a) wild-type; (b) fpgA−; and (c) fpgA+ (complemented strain).
Figure 3SDS-PAGE and gel staining of glycosylated proteins extracted from wild-type, fpgA , and fpgA (complemented fpgA ) strains. Total extracted proteins were separated by 14% SDS-PAGE gels that were (A, D) Pro-Q Emerald specific protein glycosylation; (B) silver; and (C) Coomassie blue, stained. (A) and (B): lane 1, parental; lane 2, fpgA-; and lane 3, fpgA+. In the right of each image, the position of Candy Cane (Life Technologies, Carlasbad, Cal.) with the 42 kDa and 18 kDa glycosylated proteins is indicated (lane 4). (C) and (D): lane 2, wild-type strain; lane 3, wild-type strain extract treated with proteinase K (similar results were obtained when trypsin and a mixture of both enzymes were used). Lane 1, Candy Cane (Life Technologies, Carlasbad, Cal.) molecular mass markers.